Coherus BioSciences Files 8-K on Security Holder Vote
Ticker: CHRS · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1512762
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: CHRS
TL;DR
CHRS filed an 8-K for a shareholder vote - details TBD.
AI Summary
On March 11, 2025, Coherus BioSciences, Inc. filed an 8-K report indicating that it submitted matters to a vote of its security holders. The filing does not provide details on the specific proposals voted upon or the outcome of the vote.
Why It Matters
This filing signals that Coherus BioSciences held a vote of its shareholders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any immediate financial or operational risks.
Key Players & Entities
- Coherus BioSciences, Inc. (company) — Registrant
- March 11, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 333 Twin Dolphin Drive, Suite 600 Redwood City, CA 94065 (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Coherus BioSciences' security holders?
The 8-K filing does not specify the exact proposals voted on by security holders.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 11, 2025.
What is the principal executive office address for Coherus BioSciences, Inc.?
The principal executive offices are located at 333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065.
In which state is Coherus BioSciences, Inc. incorporated?
Coherus BioSciences, Inc. is incorporated in Delaware.
What is the filing date of this 8-K report?
This 8-K report was filed as of March 13, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding Coherus BioSciences, Inc. (CHRS).